Skin cancer
We offer comprehensive and compassionate care for patients with all types of skin cancers.
Your health is our priority
Our expert team utilizes the latest treatments and technologies to ensure the best outcomes. Trust us to provide personalized care and support every step of the way.
Our services
These are some of the services we provide as part of our skin cancer program.
Biopsies
PET, MRI and CT scans
Immunotherapy
Targeted and injectable therapies
Tumor-infiltrating lymphocyte (TIL) therapy
Cutaneous (skin) medical oncology
Cutaneous (skin) radiation and surgical oncology
Clinical trials
Mohs surgery
Treating the most common types of skin cancer
- Basal cell carcinoma. This accounts for most skin cancers and can be found anywhere on the skin, especially the head and neck. It usually grows slowly and rarely spreads to other parts of the body.
- Squamous cell carcinoma. This represents about 20 percent of skin cancers and is mainly caused by sun exposure so that it may be diagnosed in many skin regions.
- Merkel cell cancer. It is a highly aggressive, rare cancer that starts in hormone-producing cells beneath the skin and hair follicles. It is usually found in the head and neck region.
- Melanoma. Melanoma is the most dangerous form of skin cancer, as it can spread to other parts of the body. It accounts for about 1 percent of all skin cancers diagnosed in the United States, but it causes most of the deaths from skin cancer.
Experienced in Mohs surgery
Our specialty-trained dermatologists have years of experience performing Mohs surgery, a dedicated treatment for certain types of skin cancer. It involves cutting away thin layers of skin at a time, looking closely for signs of cancer. The process keeps going until there are no signs of cancer and allows us to be sure that it has disappeared. It also reduces the need for other treatments or more surgery.
Melanoma treatment with TIL therapy
We now offer Tumor-infiltrating lymphocyte (TIL) therapy for patients with advanced melanoma. TIL works by using a patient’s own immune cells, called T lymphocytes, which are taken from the tumor itself. These immune cells are multiplied in a lab and then infused back into the patient’s blood stream to help fight the cancer. TIL treatment aims to boost the body's natural ability to attack the melanoma, offering hope for better outcomes.
You might be interested in
HPV-related tonsil cancer: Embracing a new normal
After an HPV-related tonsil cancer diagnosis changed the course of his life, Park City resident David Staley found strength in family, support from friends, and compassionate cancer care that helped him move forward with hope.
The bathroom changes men think are normal – but shouldn't ignore
Bathroom changes like frequent urination, weak urine flow, or waking up at night may be signs of an enlarged prostate. Learn when men should see a doctor.
Life after cancer treatment: why your care doesn't have to end when treatment does
Learn how Intermountain Health helps patients manage long‑term effects, emotional health, and follow‑up care
How oncology nurse navigators help patients overcome barriers to cancer care
Learn how oncology nurse navigators support patients and provide emotional guidance from diagnosis through recovery
AML Leukemia: Sister's lifesaving match leads to remission
Discover the inspiring journey of Rebekah Louder, a single mother of four, who defied a devastating leukemia diagnosis with unwavering hope, faith, and the support of her family
Explore your personal and family cancer history with high-risk prevention services
We help patients understand their risk for cancer, develop a personalized plan for surveillance and risk reduction, and ensure patients get appropriate care and support.
Why are younger adults getting colon cancer?
Addressing the rising trend of earlier colon cancer diagnoses
The 3 C's of Cancer Care
There are 3 main goals for treating cancer: cure, control, and comfort. When cancer is in the early stages, cure is often possible. When cancer has spread beyond where it started, the goal is to shrink a tumor and control cancer growth.
Catch Prostate Cancer Early through Screening
One in seven men will be diagnosed with prostate cancer during his lifetime with 60 percent of those cases occurring in men age 65 or older. Prostate cancer is rare before age 40, and the average age at diagnosis is 66.
Learn About Cancer Genomics
In case you missed it: latest advances in cancer research discussed at most recent Research Colloquium